Latest Blogs, News & Events

Specialty Pharmacy Beyond the U.S. Borders

Specialty pharmacy is exploding, and it’s not just in the States. While the U.S. is a global leader in specialty drug development and accessibility, market analysts are seeing unprecedented growth even in emerging and underdeveloped markets. Specialty medicine spending continues to increase quickly in developed markets, approaching half of all medicine spending in the U.S and EU5 (European Union Five: France, Germany, Italy, Spain, and the UK).

  Read More

The Growth of Orphan Drugs

In 1983, the Orphan Drug Act was enacted to incentivize pharmaceutical manufacturers to research and develop treatments for rare diseases and conditions, which are generally defined as those that affect fewer than 200,000 people. Since this law, the industry has seen a boom in efforts to treat roughly 30 million Americans who suffer from more than 7,000 rare diseases.

  Read More

Limited Distribution Networks: Industry Impact and Tips for Securing LDD Co...

The explosion of specialty drugs into the pharmaceutical market has created a greater need for structure, accountability, and therapy success. As specialty drug manufacturers look to balance patient access and safety – along with revenue and reimbursement – limited distribution networks are becoming an increasingly common strategy.

  Read More

Using TherigySTM to Satisfy URAC Standards

Following the recent URAC Specialty Pharmacy v3.0 Accreditation webinar, we sent attendees a post-event survey. We gathered results. We took a close look. And, we are responding.

  Read More

Specialty Pharmacy Consolidation: A Trend that Continues to Grow

With an estimated $115 billion in dispensed drugs and an impressive 28 percent share of the pharmaceuticals market in 2016, the specialty pharmacy industry continues to boom. This skyrocketing growth brings major opportunities to impact the healthcare market as a whole – so it’s no shock to see that specialty pharmacy mergers and acquisitions (M&As) are constantly forming and shifting the core mechanics of the industry.

  Read More

Specialty Pharmacy’s Strides in Managing Autoimmune Disorders and Rare Dise...

It’s estimated that from 2012 to 2016, orphan drug requests to the FDA doubled in volume. As of June 2017, there are more than 200 designation requests awaiting response. To remedy this, the FDA has unveiled a plan to speed responses and move these critical treatments through the pipeline.

  Read More

Poll Results and Event Recap: URAC Specialty Pharmacy v3.0 Accreditation: L...

On Tuesday, July 11, over 350 professionals from specialty pharmacies and surrounding industries converged virtually for a webinar to help them better understand how to apply the changes that were made to the patient management standards when URAC released Specialty Pharmacy v3.0 Accreditation in 2015. Here is a recap of the event and the results to the poll questions that were asked during the webinar.

  Read More

DIR Fees: The Clawback Trend

Direct and indirect remuneration (DIR) fees are one of the most controversial topics in the pharmacy industry. Proponents of DIR fees state that they help to promote quality and value among pharmacy operations, while helping to keep premiums low for Medicare beneficiaries. On the other hand, detractors argue that these fees can be confusing and misleading, and ultimately distort prescription drug prices for all parties involved.

  Read More

Therigy Partners With VUCA Health to Include On-Demand Prescription-Specifi...

Video content addition provides another important tool for pharmacies' supporting patient education adherence to specialty therapies

MAITLAND, FL, July 13, 2017  - Therigy® announced today that it has partnered with VUCA Health (Lake Mary, FL) to deliver VUCA Health patient education video content to TherigySTM™ customers.   The availability of VUCA Health video content will augment and reinforce Therigy’s existing “standard of care” clinical content which guides specialty pharmacy clinical interactions with patients.

  Read More

The Advantages and Challenges of PBMs

Pharmacy benefit managers (PBMs) first arose in the 1970’s and gained more prominence after the 2003 Medicare Modernization Act, through which Medicare Part D was created. Originally, PBMs acted as a private sector intermediary between the insurer and the pharmacy. While PBMs still fulfill this role, their significance in specialty pharmacy has skyrocketed and these powerhouse players continue to have a growing impact on drug costs, care networks, treatment accessibility, and patient outcomes.

  Read More

The New Frontier of Health Tech: How Patient Connectivity Is Enhancing Outc...

Since its inception, the healthcare industry has been constantly working to solve key universal challenges: How can we streamline and increase the effectiveness of communication and information exchange? How can we ensure that patients are fully engaged in their treatment? How can we track and measure outcomes to optimize current and future care?

  Read More

Therigy Announces Free URAC Specialty Pharmacy v3.0 Accreditation Webinar t...

Press Release – June 29, 2017 at 9:00 am EDT

  Read More

Inside TherigySTM’s Dispensing System Integrations

For specialty pharmacies and hospital systems looking to digitize and streamline their operations, it’s extremely important for different systems to be able to connect and communicate with one another. Without this capability, users might find themselves wasting critical time and increasing likelihood of data inconsistency by manually inputting information from one system to another.

  Read More

Learn Insider Tips: Don’t Miss Therigy and Cleveland Clinic’s Webinar on UR...

In three weeks, Therigy and Cleveland Clinic will host a live webinar titled Preparing for URAC Specialty Pharmacy Accreditation v3.0: Learn Insider Tips to Satisfy the Latest Patient Management Requirements. This webinar is geared toward helping specialty pharmacy leaders and clinicians who are considering the next steps toward URAC Specialty Pharmacy v3.0 accreditation.

  Read More

Small Data Is the Next Big Thing

Over the past decade, the term “big data” has represented radical growth and evolution. Sophisticated tools and resources have launched us into the digital age, with trillions of gigabytes of information available at the world’s fingertips. Organizations are able to collect, track, and organize dozens of raw data streams at a time, which has helped to uncover critical patterns and observations on a massive scale.

  Read More
  Partner with Therigy to conduct outcomes studies based on real-world evidence across 20+ specialty disease states and 400+ specialty medications.
Contact Us Today!